<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://llmtracker.de/news/goldman-sachs-zieht-claude-code-zuruck-wenn-banker-zu-vibe-codern-werden</loc>
    <news:news>
      <news:publication>
        <news:name>LLMTracker</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:00:00Z</news:publication_date>
      <news:title>Goldman Sachs zieht Claude Code zurück: Wenn Banker zu Vibe-Codern werden</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://llmtracker.de/news/ki-gegen-krankheiten-warum-pharma-ceos-den-silicon-valley-versprechen-misstrauen</loc>
    <news:news>
      <news:publication>
        <news:name>LLMTracker</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T00:00:00Z</news:publication_date>
      <news:title>KI gegen Krankheiten: Warum Pharma-CEOs den Silicon-Valley-Versprechen misstrauen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://llmtracker.de/en/news/goldman-sachs-benches-claude-code-why-the-bank-pulled-ai-from-traders-and-banker</loc>
    <news:news>
      <news:publication>
        <news:name>LLMTracker</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:00:00Z</news:publication_date>
      <news:title>Goldman Sachs Benches Claude Code: Why the Bank Pulled AI From Traders and Bankers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://llmtracker.de/en/news/ai-won-t-cure-disease-on-its-own-and-pharma-ceos-are-done-pretending-otherwise</loc>
    <news:news>
      <news:publication>
        <news:name>LLMTracker</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T00:00:00Z</news:publication_date>
      <news:title>AI Won&apos;t Cure Disease on Its Own—And Pharma CEOs Are Done Pretending Otherwise</news:title>
    </news:news>
  </url>
</urlset>
